Mankind Pharma Limited
MANKIND
Pozycja w akcjach
#2064
Mankind Pharma Limited specializes in the development, manufacturing, and... Mankind Pharma Limited specializes in the development, manufacturing, and marketing of a broad range of pharmaceutical medications and consumer health goods. Operating predominantly in India, the company also caters to international markets. Its pharmaceutical division focuses on both acute and chronic therapeutic areas, encompassing a wide spectrum of medical conditions such as infectious diseases, cardiovascular ailments, gastrointestinal disorders, diabetes, dermatology, pain management, neuro/CNS issues, nutritional support (vitamins/minerals), and respiratory problems. Complementing its pharmaceutical portfolio, the consumer healthcare segment offers diverse products, including condoms, pregnancy detection kits, emergency contraceptives, antacid powders, vitamin and mineral supplements, and anti-acne preparations. Key brands under its umbrella include Manforce, Prega News, Unwanted-72, Gas-O-Fas, Health OK, and AcneStar. Furthermore, the company's business activities are diversified, extending to the trading and export of pharmaceutical and healthcare products, as well as the manufacturing of various goods such as packaging materials, ayurvedic products, bulk drugs, and general consumer items. Mankind Pharma also holds interests in real estate, leasing, hospitality, and IT services. Established in 1986, Mankind Pharma Limited maintains its headquarters in New Delhi, India.
Cena akcji
$24.08
Kapitalizacja rynkowa
$9.95B
Zmiana (1 dzień)
-4.09%
Zmiana (1 rok)
-13.33%
Kraj
IN
Handel Mankind Pharma Limited (MANKIND)
Kategoria
Healthcare
Przychody dla Mankind Pharma Limited (MANKIND)
Przychody w Oct 2026 TTM: 0
Według najnowszych raportów finansowych Mankind Pharma Limited, obecny przychód firmy (TTM) wynosi 0. W roku 2026 firma osiągnęła przychód w wysokości 0 równa się przychodu z roku 2026, który wynosił 0. Przychód to całkowita kwota dochodu generowana przez firmę ze sprzedaży towarów lub usług. W przeciwieństwie do zysku, nie są odliczane żadne koszty.
Historia przychodów firmy Mankind Pharma Limited od 2019 do 2026
Przychody na koniec każdego roku
| Rok | Przychody | Zmień |
|---|---|---|
| 2025 | $1.43B | 16.01% |
| 2024 | $1.23B | 15.57% |
| 2023 | $1.06B | 3.86% |
| 2022 | $1.03B | 20.75% |
| 2021 | $848.92M | 9.04% |
| 2020 | $778.55M | 8.56% |
| 2019 | $717.16M | 0.00% |
Przychody podobnych firm lub konkurentów
| Firma | Przychody | Różnica w przychodach | Kraj |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $6.61B | - |
IN
|
